About
LeonaBio develops and clinically trials novel small molecule therapies, including lasofoxifene and brelgometon, targeting diseases with limited current treatment options.
Explore LeonaBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.